ICU启动肾脏替代治疗患者:80岁起存活者更少且更多依赖透析
该研究为法国巴黎地区两家教学医院ICU的前瞻性数据回顾性汇总分析,纳入1530例在ICU启动肾脏替代治疗的成人急性肾损伤患者,按年龄五分位评估出院时存活与慢性透析依赖。死亡率从Q1(≤52岁)63%升至Q5(≥80岁)76%(p<0.001);调整后80岁前年龄不增加死亡风险,≥80岁者死亡风险显著升高(调整OR 2.59,95%CI 1.66-4.03)。存活者中≥80岁者透析依赖更常见(30% vs 14%,p=0.001),基线eGFR是透析依赖的唯一预测因素。
要点
- ≥80岁ICU启动肾脏替代治疗者调整后死亡风险显著升高:调整OR 2.59(95%CI 1.66-4.03)。
- 死亡率随年龄五分位升高:Q1(≤52岁)63%至Q5(≥80岁)76%(p<0.001)。
- 存活者中≥80岁者透析依赖更常见:30% vs 14%(p=0.001)。
- 基线eGFR是透析依赖的唯一预测因素;≥80岁仅为既往晚期慢性肾脏病者透析依赖的独立风险(p=0.04)。
- ≥80岁者基线eGFR>44 mL/min/1.73 m时可能恢复足够肾功能而停用肾脏替代治疗;3个月时仅6%在家且不依赖透析。
适用人群与场景
- 法国巴黎地区两家教学医院ICU的1530例成人患者,均在ICU启动肾脏替代治疗。
- 纳入标准为需在ICU启动肾脏替代治疗的成人急性肾损伤患者;排除标准原文未报告。
- 73%的纳入患者在启动肾脏替代治疗时有呼吸和血流动力学支持,各年龄五分位分布相似。
研究设计与关键结果
- 研究类型:前瞻性收集数据的回顾性汇总分析;样本量1530例;两家教学医院ICU;人群为ICU启动肾脏替代治疗的成人急性肾损伤患者。
- 主要终点:死亡率随年龄五分位从Q1(≤52岁)63%升至Q5(≥80岁)76%(p<0.001)。
- 调整后80岁前年龄不增加死亡风险;≥80岁者死亡风险显著升高(调整OR 2.59,95%CI 1.66-4.03)。
- 存活者中≥80岁者透析依赖更常见:30% vs 14%(p=0.001)。
- ≥80岁仅为既往晚期慢性肾脏病者透析依赖的独立风险(p=0.04);基线eGFR是透析依赖的唯一预测因素。
- ≥80岁者基线eGFR>44 mL/min/1.73 m时可能恢复足够肾功能而停用肾脏替代治疗;3个月时仅6%在家且不依赖透析。
证据类型、等级与局限
- 证据类型:前瞻性收集数据的回顾性汇总分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对≥80岁ICU启动肾脏替代治疗者,应将年龄视为独立于器官衰竭严重程度的额外死亡风险(调整OR 2.59,95%CI 1.66-4.03)。
- ≥80岁存活者出院时透析依赖更常见(30% vs 14%,p=0.001),基线eGFR是唯一预测因素;基线eGFR>44 mL/min/1.73 m者可能恢复足够肾功能而停用肾脏替代治疗。
- 3个月时仅6%在家且不依赖透析,适用于与家属沟通出院去向及长期透析依赖风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the role of advanced age on survival and dialysis dependency after initiation of renal replacement therapy for acute kidney injury.
DESIGN: Retrospective pooled analysis of prospectively collected data.
SETTING: ICUs of two teaching hospitals in Paris area, France.
SUBJECTS: One thousand five hundred thirty adult patients who required renal replacement therapy initiation in the ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Survival and post acute kidney injury chronic dialysis dependency were assessed at hospital discharge according to the quintile (Q) of age. The oldest quintile included 289 patients 80 years old and over. Seventy-three percent of included patients had respiratory and hemodynamic supports at renal replacement therapy initiation, similarly distributed across quintiles. Mortality increased with age strata from 63% in Q1 (≤ 52 yr) to 76% in Q5 (≥ 80 yr) (p < 0.001). After adjustment, age did not increase the risk of death up to 80 years. The oldest patients (≥ 80 yr) had a significant higher risk of dying (adjusted odds ratio, 2.59; 95% CI, 1.66-4.03). Dialysis dependency was more frequent among survivors 80 years old or older (30% vs 14%; p = 0.001). Age 80 years old or older was an independent risk for dialysis dependency only for patients with prior advanced chronic kidney disease (p = 0.04). Baseline estimated glomerular filtration rate was the only one predictor of dialysis dependency identified.
CONCLUSIONS: Patients with advanced age represent a substantial subgroup of patients requiring renal replacement therapy in the ICU. From 80 years, age should be considered as an additional risk of dying over the severity of organ failures. Patients 80 years old or older are likely to recover sufficient renal function allowing renal replacement therapy discontinuation when baseline estimated glomerular filtration rate is above 44 mL/min/1.73 m. At 3 months, only 6% were living at home, dialysis independent.
参考来源
- Commereuc M, Guérot E, Charles-Nelson A, et al. ICU Patients Requiring Renal Replacement Therapy Initiation: Fewer Survivors and More Dialysis Dependents From 80 Years Old. Crit Care Med. 2017. PMID: 28437374. doi:10.1097/CCM.0000000000002407
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。